182 related articles for article (PubMed ID: 14728807)
1. Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog.
Pan GJ; Pei DQ
Cell Res; 2003 Dec; 13(6):499-502. PubMed ID: 14728807
[TBL] [Abstract][Full Text] [Related]
2. Identification of a putative transactivation domain in human Nanog.
Oh JH; Do HJ; Yang HM; Moon SY; Cha KY; Chung HM; Kim JH
Exp Mol Med; 2005 Jun; 37(3):250-4. PubMed ID: 16000880
[TBL] [Abstract][Full Text] [Related]
3. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human.
Hart AH; Hartley L; Ibrahim M; Robb L
Dev Dyn; 2004 May; 230(1):187-98. PubMed ID: 15108323
[TBL] [Abstract][Full Text] [Related]
4. The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus.
Pan G; Pei D
J Biol Chem; 2005 Jan; 280(2):1401-7. PubMed ID: 15502159
[TBL] [Abstract][Full Text] [Related]
5. Identification and functional characterization of an alternative splice variant within the fourth exon of human nanog.
Kim JS; Kim J; Kim BS; Chung HY; Lee YY; Park CS; Lee YS; Lee YH; Chung IY
Exp Mol Med; 2005 Dec; 37(6):601-7. PubMed ID: 16391521
[TBL] [Abstract][Full Text] [Related]
6. Nanog and transcriptional networks in embryonic stem cell pluripotency.
Pan G; Thomson JA
Cell Res; 2007 Jan; 17(1):42-9. PubMed ID: 17211451
[TBL] [Abstract][Full Text] [Related]
7. The C-terminal pentapeptide of Nanog tryptophan repeat domain interacts with Nac1 and regulates stem cell proliferation but not pluripotency.
Ma T; Wang Z; Guo Y; Pei D
J Biol Chem; 2009 Jun; 284(24):16071-16081. PubMed ID: 19366700
[TBL] [Abstract][Full Text] [Related]
8. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.
Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768
[TBL] [Abstract][Full Text] [Related]
9. Two potent transactivation domains in the C-terminal region of human NANOG mediate transcriptional activation in human embryonic carcinoma cells.
Do HJ; Lee WY; Lim HY; Oh JH; Kim DK; Kim JH; Kim T; Kim JH
J Cell Biochem; 2009 Apr; 106(6):1079-89. PubMed ID: 19229867
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the human NANOG protein.
Chang DF; Tsai SC; Wang XC; Xia P; Senadheera D; Lutzko C
Stem Cells; 2009 Apr; 27(4):812-21. PubMed ID: 19350681
[TBL] [Abstract][Full Text] [Related]
11. Identification of an N-terminal transcriptional activation domain within Brn3b/POU4f2.
Martin SE; Mu X; Klein WH
Differentiation; 2005 Feb; 73(1):18-27. PubMed ID: 15733064
[TBL] [Abstract][Full Text] [Related]
12. Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma.
Clark AT; Rodriguez RT; Bodnar MS; Abeyta MJ; Cedars MI; Turek PJ; Firpo MT; Reijo Pera RA
Stem Cells; 2004; 22(2):169-79. PubMed ID: 14990856
[TBL] [Abstract][Full Text] [Related]
13. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.
Chambers I; Colby D; Robertson M; Nichols J; Lee S; Tweedie S; Smith A
Cell; 2003 May; 113(5):643-55. PubMed ID: 12787505
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain.
Theunissen TW; Costa Y; Radzisheuskaya A; van Oosten AL; Lavial F; Pain B; Castro LF; Silva JC
Development; 2011 Nov; 138(22):4853-65. PubMed ID: 22028025
[TBL] [Abstract][Full Text] [Related]
15. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.
Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H
Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932
[TBL] [Abstract][Full Text] [Related]
16. Aromatic residues in the C-terminal domain 2 are required for Nanog to mediate LIF-independent self-renewal of mouse embryonic stem cells.
Wang Z; Ma T; Chi X; Pei D
J Biol Chem; 2008 Feb; 283(8):4480-9. PubMed ID: 18086680
[TBL] [Abstract][Full Text] [Related]
17. Network plasticity of pluripotency transcription factors in embryonic stem cells.
Filipczyk A; Marr C; Hastreiter S; Feigelman J; Schwarzfischer M; Hoppe PS; Loeffler D; Kokkaliaris KD; Endele M; Schauberger B; Hilsenbeck O; Skylaki S; Hasenauer J; Anastassiadis K; Theis FJ; Schroeder T
Nat Cell Biol; 2015 Oct; 17(10):1235-46. PubMed ID: 26389663
[TBL] [Abstract][Full Text] [Related]
18. The homeodomain protein Nanog and pluripotency in mouse embryonic stem cells.
Yates A; Chambers I
Biochem Soc Trans; 2005 Dec; 33(Pt 6):1518-21. PubMed ID: 16246159
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog.
Jauch R; Ng CK; Saikatendu KS; Stevens RC; Kolatkar PR
J Mol Biol; 2008 Feb; 376(3):758-70. PubMed ID: 18177668
[TBL] [Abstract][Full Text] [Related]
20. Developmental expression of pluripotency determining factors in caprine embryos: novel pattern of NANOG protein localization in the nucleolus.
He S; Pant D; Schiffmacher A; Bischoff S; Melican D; Gavin W; Keefer C
Mol Reprod Dev; 2006 Dec; 73(12):1512-22. PubMed ID: 16894532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
